BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.12% |
| 2 | Healthcare | 13.68% |
| 3 | Financials | 13.15% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVTA
2101
DELISTED
Avantax, Inc. Common Stock
AVTA
| $119M | ﹤0.01% |
7,624,883
-170,723
| -2% | -$2.76M |
|
2102
Insteel Industries
IIIN
$633M
| $119M | ﹤0.01% |
3,115,550
-56,962
| -2% | -$2.1M |
|
2103
John B. Sanfilippo & Son
JBSS
$978M
| $118M | ﹤0.01% |
1,450,034
-36,620
| -2% | -$3.18M |
|
|
ENDP
2104
DELISTED
Endo International plc
ENDP
| $118M | ﹤0.01% |
36,427,206
-461,879
| -1% | -$1.63M |
|
2105
Par Pacific Holdings
PARR
$3.78B
| $118M | ﹤0.01% |
7,493,196
-216,900
| -3% | -$3.36M |
|
2106
Pilgrim's Pride
PPC
$6.4B
| $118M | ﹤0.01% |
4,042,948
-237,309
| -6% | -$5.95M |
|
|
CCRN
2107
DELISTED
Cross Country Healthcare
CCRN
| $118M | ﹤0.01% |
5,534,223
-118,643
| -2% | -$2.23M |
|
2108
Delek US
DK
$3.92B
| $118M | ﹤0.01% |
6,540,237
-417,759
| -6% | -$7.12M |
|
|
ANAT
2109
DELISTED
American National Group, Inc. Common Stock
ANAT
| $117M | ﹤0.01% |
618,701
+33,675
| +6% | +$5.99M |
|
2110
Quanex
NX
$1.01B
| $117M | ﹤0.01% |
5,460,611
-176,585
| -3% | -$4.12M |
|
2111
Castle Biosciences
CSTL
$985M
| $117M | ﹤0.01% |
1,756,008
+64,010
| +4% | +$4.5M |
|
2112
HealthStream
HSTM
$829M
| $117M | ﹤0.01% |
4,080,947
-107,848
| -3% | -$3.15M |
|
2113
Kosmos Energy
KOS
$1.52B
| $116M | ﹤0.01% |
39,350,783
-1,219,373
| -3% | -$2.97M |
|
2114
Butterfly Network
BFLY
$2.5B
| $116M | ﹤0.01% |
11,141,663
+5,650,885
| +103% | +$65.2M |
|
|
CMO
2115
DELISTED
Capstead Mortgage Corp.
CMO
| $116M | ﹤0.01% |
17,375,817
-636,259
| -4% | -$4.17M |
|
2116
McGrath RentCorp
MGRC
$2.95B
| $116M | ﹤0.01% |
1,615,326
-344,939
| -18% | -$25.4M |
|
|
DRNA
2117
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $116M | ﹤0.01% |
5,763,585
-11,949
| -0.2% | -$330K |
|
2118
American Well
AMWL
$221M
| $116M | ﹤0.01% |
636,343
+69,896
| +12% | +$15.2M |
|
|
CUTR
2119
DELISTED
Cutera, Inc.
CUTR
| $116M | ﹤0.01% |
2,486,879
-190,953
| -7% | -$9.42M |
|
2120
Bristow Group
VTOL
$1.37B
| $115M | ﹤0.01% |
3,624,086
+787,498
| +28% | +$23M |
|
2121
Prudential
PUK
$34B
| $115M | ﹤0.01% |
2,943,951
+278,012
| +10% | +$10.8M |
|
2122
Organogenesis Holdings
ORGO
$243M
| $115M | ﹤0.01% |
8,074,108
+1,052,935
| +15% | +$16.4M |
|
2123
Microvision
MVIS
$86.6M
| $115M | ﹤0.01% |
693,664
+5,471
| +0.8% | +$1.14M |
|
2124
Kelly Services Class A
KELYA
$536M
| $115M | ﹤0.01% |
6,087,339
+130,857
| +2% | +$2.74M |
|
|
ARGO
2125
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $115M | ﹤0.01% |
2,199,676
-112,431
| -5% | -$5.91M |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.